BioSpace News Archive

Released in the form of a User Guide for data managers, statisticians, programmers and study managers, the standard is freely available on the CDISC website.

Mushkin and partner Matt Siler’s R5 Capital reimagines research by using proprietary “boots on the ground” analysis in conjunction with data analytics to help generate alpha for institutional equity investors and to provide unique strategic consulting services for corporations in the retail and consumer sectors

Vetter announced that its US clinical manufacturing facility located at the Illinois Science+Technology Park in Skokie has been named as one of “Chicago’s Best and Brightest Companies to Work For®”.

Polaris RZR®, the world’s No.1-selling sport performance side-by-side, and Nitro Circus, the worldwide leader in action sports entertainment, have partnered to deliver the ultimate adrenaline rush to the Camp RZR 2019 event.

INTELLiSTEM Technologies, an international company revolutionizing stem cell medicine, today announced that they have created genetically engineered Super Sentinel Cells™ (SSC’s) to effectively target cancer cells.

BrightWater Medical, Inc. (BrightWater), the manufacturer of a groundbreaking stent, announced that it has successfully completed the sale of the organization to Utah-based Merit Medical Systems, Inc.

Join the Lustgarten Foundation and walk leader Jeanne Weber on Sunday, September 22nd, for the annual Lustgarten Foundation Pancreatic Cancer Research Walk at Bergen Community College in Paramus, New Jersey.

Today the National Safety Council (NSC) made specific asks of the American business community and unveiled a new toolkit that employers can use to address the opioid crisis

CDISC is pleased to announce the first release of a global Therapeutic Area Standard using Traditional Chinese Medicine. Specifically, the standard describes how to use CDISC standards to represent data pertaining to coronary artery disease for the treatment of angina.

OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS), today announced the appointment of Robert Petit, Ph.D., as its Chief Medical and Scientific Advisor.